Dow Up 0.69% Nasdaq Up 0.51%

United Therapeutics Corporation (UTHR)

-NasdaqGS
130.75 Up 1.53(1.18%) 11:27AM EST - Nasdaq Real Time Price
Prev Close:129.22
Open:130.85
Bid:130.36 x 200
Ask:130.50 x 100
1y Target Est:124.71
Beta:1.37
Next Earnings Date:N/A
Day's Range:129.20 - 131.55
52wk Range:84.63 - 136.93
Volume:180,875
Avg Vol (3m):993,920
Market Cap:6.21B
P/E (ttm):36.87
EPS (ttm):3.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
UTHRUp 1.18%6.21B
GILDUp 0.16%152.00B
PFEUp 0.10%191.98B

Key Statistics

Forward P/E (1 yr):13.07
P/S (ttm):4.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.04
Quarterly EPS Est (Dec-14) :2.18
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback